BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹15 Cr | ₹22 Cr | ₹9.48 Cr | ₹4.95 Cr | ₹9.73 Cr |
What is the latest Cash Flow from Operating Activities ratio of BAFNA PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹15 Cr |
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹9.48 Cr |
| Mar2023 | ₹4.95 Cr |
| Mar2022 | ₹9.73 Cr |
How is Cash Flow from Operating Activities of BAFNA PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹15 Cr | -30.56 | |
| Mar2025 | ₹22 Cr | 133.38 | |
| Mar2024 | ₹9.48 Cr | 91.50 | |
| Mar2023 | ₹4.95 Cr | -49.09 | |
| Mar2022 | ₹9.73 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹1,065.8 Cr | -4% | 28.9% | 191.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -4% |
28.9% |
191.2% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses